Planta Med 2005; 71(8): 727-732
DOI: 10.1055/s-2005-871255
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Sulphated Oligosaccharides as Inhibitors of Hyaluronidases from Bovine Testis, Bee Venom and Streptococcus agalactiae

Sunnhild Salmen1 , Julia Hoechstetter1 , Christian Käsbauer1 , Dieter H. Paper1 , Günther Bernhardt1 , Armin Buschauer1
  • 1Institute of Pharmacy, University of Regensburg, Regensburg, Germany
Further Information

Publication History

Received: October 29, 2004

Accepted: April 20, 2005

Publication Date:
08 August 2005 (online)

Abstract

Potent and specific inhibitors of hyaluronidases, a group of enzymes preferentially catalysing the hydrolysis of hyaluronic acid, are not known so far. Such compounds could be useful as pharmacological tools for studying the physiological and pathophysiological role of both hyaluronan and hyaluronidases. The effects of sulphated and non-sulphated structurally different oligosaccharides on bovine testicular hyaluronidase, hyaluronidase from bee venom and hyaluronate lyase from Streptococcus agalactiae (hylB4755) were studied with the Morgan-Elson reaction. Several active compounds were identified within a series of sulphated β-(1,4)-galacto-oligosaccharides. The determined IC50 values of these sulphated oligosaccharides ranged from 4 μM to 630 μM for all hyaluronan-degrading enzymes. Sulphated oligosaccharides like verbascose, planteose and neomycin showed comparable inhibition on all hyaluronidases, thereby possessing 100 - 500 times the activity of the widely accepted hyaluronidase inhibitor apigenin.

References

  • 1 Hascall V C, Yanagishita M. Science of hyaluronan today. Glycoforum: http://www.glycoforum.gr.jp/
  • 2 Kreil G. Hyaluronidases - A group of neglected enzymes.  Prot Sci. 1995;  4 1666-9
  • 3 Menzel E, Farr C. Hyaluronidase and its substrate hyaluronan: Biochemistry, biological activities and therapeutic uses.  Cancer Lett. 1998;  131 3-11
  • 4 Mio K, Stern R. Inhibitors of the hyaluronidases.  Matrix Biol. 2002;  21 31-7
  • 5 Meyer K. The biological significance of hyaluronic acid and hyaluronidase.  Physiol Rev. 1947;  27 335-59
  • 6 Meyer K, Rapport M M. Hyaluronidases.  Adv Enzymol. 1952;  13 199-236
  • 7 Meyer K, Rapport M M. The inhibition of testicular hyaluronidase by heavy metals.  J Biol Chem. 1951;  188 485-90
  • 8 Meyer K, Ragan C. The antirheumatic effect of sodium gentisate.  Science. 1948;  108 281
  • 9 Li S, Taylor K B, Kelly S J, Jedrzejas M J. Vitamin C inhibits the enzymatic activity of Streptococcus pneumoniae hyaluronate lyase.  J Biol Chem. 2001;  276 15 125-30
  • 10 Kakegawa H, Matsumoto H, Satoh T. Inhibitory effects of some natural products on the activation of hyaluronidase and their anti-allergic actions.  Chem Pharm Bull. 1992;  40 1439-42
  • 11 Kakegawa H, Matsumoto H, Satoh T. Inhibitory effects of hydrangenol derivatives on the activation of hyaluronidase and their antiallergic activities.  Planta Med. 1988;  54 385-9
  • 12 Kuppusamy U R, Das N P. Inhibitory effects of flavonoids on several venom hyaluronidases.  Experientia. 1991;  47 1196-200
  • 13 Kuppusamy U R, Khoo H E, Das N P. Structure-activity studies of flavonoids as inhibitors of hyaluronidase.  Biochem Pharmacol. 1990;  40 397-401
  • 14 Kuppusamy U R, Das N P. Protective effects of tannic acid and related natural compounds on Crotalus adamenteus subcutaneous poisoning in mice.  Pharmacol Toxicol. 1993;  72 290-5
  • 15 Toida T, Ogita Y, Suzuki A, Toyoda H, Imanari T. Inhibition of hyaluronidase by fully O-sulfonated glycosaminoglycans.  Arch Biochem Biophys. 1999;  370 176-82
  • 16 Käsbauer C W. Synthese von sulfatierten Oligosacchariden und Glycosiden und ihre Testung auf antiangiogene Wirkung. PhD Thesis, University of Regensburg 1999
  • 17 Käsbauer C W, Paper D H, Franz G. Sulfated beta-(1→4)-galacto-oligosaccharides and their effect on angiogenesis.  Carbohydr Res. 2001;  330 427-30
  • 18 Oettl M, Hoechstetter J, Asen I, Bernhardt G, Buschauer A. Comparative characterization of bovine testicular hyaluronidase and a hyaluronate lyase from Streptococcus agalactiae in pharmaceutical preparations.  Eur J Pharm Sci. 2003;  18 267-77
  • 19 Gmachl M, Kreil G. Bee venom hyaluronidase is homologous to a membrane protein of mammalian sperm.  Proc Natl Acad Sci USA. 1993;  90 3569-73
  • 20 Soldatova L N, Crameri R, Gmachl M, Kemeny D M, Schmidt M, Weber M, Mueller U R. Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli .  J Allergy Clin Immunol. 1998;  101 691-8
  • 21 Muckenschnabel I, Bernhardt G, Spruss T, Dietl B, Buschauer A. Quantitation of hyaluronidases by the Morgan-Elson reaction: comparison of the enzyme activities in the plasma of tumor patients and healthy volunteers.  Cancer Lett. 1998;  131 13-20
  • 22 Asada M, Sugie M, Inoue M, Nakagomi K, Hongo S, Murata K, Irie S, Takeuchi T, Tomizuka N, Oka S. Inhibitory effect of alginic acids on hyaluronidase and on histamine release from mast cells.  Biosci Biotechnol Biochem. 1997;  61 1030-2
  • 23 Houck J C. The competitive inhibition of hyaluronidase.  Arch Biochem. 1957;  71 336-41
  • 24 Botzki A, Rigden D J, Braun S, Nukui M, Salmen S, Hoechstetter J, Bernhardt G, Dove S, Jedrzejas M J, Buschauer A. L-Ascorbic acid-6-hexadecanoate, a potent hyaluronidase inhibitor: X-ray structure and molecular modeling of enzyme-inhibitor complexes.  J Biol Chem. 2004;  279 45 990-7

Prof. Dr. Armin Buschauer

Institute of Pharmacy

University of Regensburg

93040 Regensburg

Germany

Fax: +49-941-9434820

Email: armin.buschauer@chemie.uni-regensburg.de

    >